Results 111 to 120 of about 16,858 (143)

Increasing proportion and more favourable outcomes of seronegative rheumatoid arthritis: analysis of the IORRA cohort from 2000 to 2021. [PDF]

Clin Rheumatol
Higuchi T, Tanaka E, Inoue E, Sugano E, Ikari K, Harigai M.   +5 more
europepmc   +1 more source

A Photothermally Triggered Nanoplatform for Multidimensional Antibacterial Therapy and Accelerated Healing of Infected Wounds. [PDF]

Int J Nanomedicine
Fan Y, Li J, Wang P, Peng Y, Yan C, Li X, Wang Z, Li X, He Z, Li W, Yin B, Jia C.   +11 more
europepmc   +1 more source

Cardiac-homing peptide-targeted colchicine-based drugstores with inhibiting inflammatory response for myocardial infarction improvement. [PDF]

Mater Today Bio
Zhang X, Xu W, Song J, Ding H, Yu S, Yang N, Taiwaikuli D, Chen Y, Lu Y, Tang B, Fan Z, Zhou X.   +11 more
europepmc   +1 more source

Tubulin monoglutamylation is sufficient to rescue the ciliary motility defects in a <i>Chlamydomonas</i> polyglutamylation deficient mutant. [PDF]

Front Cell Dev Biol
Sasaki R, Oda T, Kubo T.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis

Clinical Rheumatology, 2006
Our aim is to assess the prevalence and associated clinical features of anti-CCP (cyclic citrullinated peptide) antibodies for RF (rheumatoid factor)-positive and RF-negative rheumatoid arthritis (RA) and psoriatic arthritis (PsA). In a prospective, cross-sectional, multi-centre study, we determined the titres of anti-CCP antibodies in 208 RA patients (
İNANÇ, Murat, DİRESKENELİ, RAFİ HANER, Elbir, Y., Kasapoglu-Gunal, E., Kamali, S., Dalkilic, E., İNANÇ, Murat   +6 more
openaire   +4 more sources

Redefining the HLA and RA association: To be or not to be anti-CCP positive

Journal of Autoimmunity, 2005
Rheumatoid Arthritis (RA) is the most common chronic inflammatory joint disease. The overall prevalence is 1% and in people older than 60 it is more than 2%. RA has auto-immune features: auto-antibodies against the Fc part of IgG, so-called Rheumatoid Factor (RF) are found more often in RA patients and more recently RA-specific auto-antibodies directed
René R P, de Vries, Tom W J, Huizinga, René E M, Toes   +2 more
openaire   +2 more sources

Anti-CCP biosensors in rheumatoid arthritis

Clinica Chimica Acta
Biosensors are unique analytical tools for the detection of biomarkers. Of these, autoantibodies against citrullinated proteins (ACPA) are useful for the differential diagnosis of rheumatoid arthritis (RA). The autoantibodies may be detected by immunoassay technology using synthetic cyclic citrullinated peptides (CCP), ie, anti-CCP.
Pari Karami, Danial Gholamin, Farzaneh Fathi, Taha Afsar, Mohammad Johari-Ahar   +4 more
openaire   +2 more sources

The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels

Annals of the Rheumatic Diseases, 2008
Patients presenting with both arthralgia and antibodies to cyclic citrullinated peptide (anti-CCP) have an increased risk of developing rheumatoid arthritis (RA). To further characterise this patient group and shed more light on its relationship with clinically manifest early arthritis and established RA, an immunogenetic and serological analysis was ...
Bos, W. H., Ursum, J., de Vries, N. [=Niek], Bartelds, G. M., Wolbink, G. J., Nurmohamed, M. T., van der Horst-Bruinsma, I. E., van de Stadt, R. J., Crusius, J. B. A., Tak, P. P., Dijkmans, B. A. C., van Schaardenburg, D.   +11 more
openaire   +4 more sources

The continuous measurement of anti-CCP-antibodies does not help to evaluate the disease activity in anti-CCP-antibody-positive patients with rheumatoid arthritis

Clinical Rheumatology, 2010
Anti-cyclic citrullinated peptide antibody (CCP-AB) are used for diagnosis of rheumatoid arthritis (RA). It is still unknown if the extent of CCP-AB levels is useful to assess the disease activity or the individual follow-up as an individual activity parameter. We investigated 40 patients with a known RA who were positive for CCP-AB.
Thoren, Landmann, Gabriele, Kehl, Raoul, Bergner   +2 more
openaire   +2 more sources

Rheumatoid Factor and Anti-CCP Titers in COVID-19

Infectious Disorders - Drug Targets
Introduction: The mechanisms of Coronavirus Disease 2019 (COVID-19) remain not fully elucidated. The present study aimed to trace the presence of autoantibodies among COVID-19 patients and to determine the association between COVID-19 and these antibodies.
Mudathir Abdelshafea Abdelkareem Abakar, Mohamed Ibrahim Awadab, Zohair Khalid Ibrahim Elaraki, Mohammed Elsheikh Osman, Mohamed Ahmed Ibrahim–Holi, Eltayib Hassan Ahmed-Abakur, Tarig M. S. Alnour   +6 more
openaire   +2 more sources